Mena FN

Neoimmunetech To Partner With U.S. National Institute Of Allergy And Infectious Diseases (NIAID), National Institutes Of Health (NIH) For Drug Development In Acute Radiation ...

ROCKVILLE, Md., Jan. 3, 2023 /PRNewswire/ -- NeoImmuneTech, Inc. (NIT or 'NeoImmuneTech'), a clinical-stage T cell-focused biopharmaceutical company, today announced an agreement with the National ...
Business Wire

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next ...

MUMBAI, India & HYDERABAD, India--(BUSINESS WIRE)--PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational ...
Business Wire

Lactiga Secures Multi-Year, Multi-Million Dollar Grant from NIH’s National Institute of Allergy and Infectious Diseases to Advance Groundbreaking, Mucosal-Targeted Secretory ...

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Lactiga, a biotech company leading the development of naturally-occurring antibody therapies for inflammatory and immunodeficient conditions, has been awarded a ...
The Scientist

NIAID Moves Away from Biodefense; Experts are Worried.

The National Institute of Allergy and Infectious Diseases’s strategic plan for 2026–2030 also omitted emerging infectious ...